
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages. Initials approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed
Biotech,biotechnology,life sciences,pharmaceuticals,drug discovery,and drug development
Initial therapeutics operates in the Biotechnology research industry.
Initial therapeutics's revenue is 1m - 10m
Initial therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.